Drugs for Schistosomiasis Market Size By Drug Type, By Application and By Region – Global Trends and Forecast to 2027

 Breaking News
  • No posts were found

Drugs for Schistosomiasis Market Size By Drug Type, By Application and By Region – Global Trends and Forecast to 2027

August 05
16:20 2021
Drugs for Schistosomiasis Market Size By Drug Type, By Application and By Region - Global Trends and Forecast to 2027
The market for Drugs for Schistosomiasis is expected to reach USD 103.4 million in 2027, up from USD 73.4 million in 2020. During the forecast period, the market is expected to grow at a CAGR of 5.6 percent.

The Drugs for Schistosomiasis market is estimated to reach at USD 103.4 million in 2027 from USD 73.4 million in 2020. The market is anticipated to grow at a CAGR of 5.6% during the forecast timeline 

Schistosomiasis is an infection acquired by people while coming into contact with the water-containing larva of schistosomes. The adult form of the worms lives inside the intestines and urinary tracts of humans. According to the World Health Organization, nearly 200000 people die due to schistosomiasis annually. The “Global Drugs for Schistosomiasis Market” offers comprehensive and precise insights on this market.

Browse the full report at https://www.credenceresearch.com/report/drugs-for-schistosomiasis-market

Key Market Drivers and Restraints

This report includes detailed analysis of factors expected to fuel the growth of Drugs for Schistosomiasis market. Moreover, it also covered the major factors likely to hamper the market growth and helps in identifying growth pockets. 

Impact of COVID 19

COVID 19 has significantly impacted the global Drugs for Schistosomiasis market. It affected the demand and sales of Drugs for Schistosomiasis, as hospitals put more emphasis on the treatment of COVID 19 patients. It affected the detection and treatment of Schistosomiasis. Global Drugs for Schistosomiasis market reported around 19.2% decline in its revenue as compared to 2019. With the COVID 19 cases decreasing significantly around the world, the global Drugs for Schistosomiasis market is anticipated to regain its pre-COVID 19 levels soon. 

North America is expected to lead the global Drugs for Schistosomiasis market

The global Drugs for Schistosomiasis market is segmented into six geographies with all major economies pertaining to it. The report offers a comprehensive insight on major regional markets. By Region, North America is expected to lead the global market throughout the forecast period by holding 28.9% revenue share in 2020. 

Global Drugs for Schistosomiasis Market is dominated by the demand for Praziquantel     

Biltricide, Artemisinins, Metrifonate, Oxamniquine and Praziquantel are the major drugs for schistosomiasis. However, Praziquantel is the most effective drug available in the market for different species of Schistosoma. It accounted for the vast majority of the revenue generated in the Drugs for Schistosomiasis market with a share of over 25% in 2020. There are many pipeline drugs in the clinical trial stage.

The increasing number of schistosomiasis patients drives the global demand for Drugs for Schistosomiasis

The improving healthcare facilities in developing countries around the world is increasing the number of detections of schistosomiasis patients. Increasing pollution in rivers, lakes, and ponds in tropical and sub-tropical countries is providing breeding grounds for Schistosoma species that cause the infection. Nearly 700 million people live in endemic countries and it increases the risk of infection.  Africa and the Middle East account for 42.1% share of the total revenue generated by the global Drugs for Schistosomiasis industry.

Browse the full report at https://www.credenceresearch.com/report/drugs-for-schistosomiasis-market

Market Segmentation

Global Drugs for Schistosomiasis Market by Drug Type, 2015 – 2027

· Artemisinins

· Biltricide

· Corticosteroids

· Metrifonate

· Trioxolanes

· Praziquantel    

· Oxamniquine

· Others

Global Drugs for Schistosomiasis Market by Application, 2015 – 2027

· Schistosoma Guineensis

· Schistosoma Haematobium

· Schistosoma Intercalatum

· Schistosoma Japonicum

· Schistosoma Mansoni

· Schistosoma Mekongi

Global Drugs for Schistosomiasis Market by Distribution Channel, 2015 – 2027

· Hospital Pharmacy

· Online Pharmacy

· Retail Pharmacy

Global Drugs for Schistosomiasis Market by Region, 2015 – 2027

· North America

· Europe

· Asia Pacific

· Latin America

· Middle East and Africa

Global Drugs for Schistosomiasis Market: Key Players

· Bayer AG

· Chandra Bhagat Pharma Ltd

· EIPICO

· Merck & Co Inc

· Pfizer Inc

· Par Pharmaceutical Inc

· Samarth Pharma Pvt Ltd

· Sanofi SA

· Shin Poong Pharm Co Ltd

. Taj Pharmaceuticals Ltd

Key Question Answered in the Report:

  • What are the consequences of COVID 19 on global Drugs for Schistosomiasis industry?
  • Who are the top five players in the global Drugs for Schistosomiasis industry?
  • Which is the fastest growing application market for global Drugs for Schistosomiasis industry?
  • Which is the leading regional market for global Drugs for Schistosomiasis industry?
  • What will be the CAGR (2021 – 2027) of in global Drugs for Schistosomiasis industry?
  • What was the volume and revenue of global Drugs for Schistosomiasis industry in 2015?
  • Which are the growing technological trends in in global Drugs for Schistosomiasis industry?
  • Which are the major driving forces behind growth of global Drugs for Schistosomiasis industry?
  • What are the key growth pockets within global Drugs for Schistosomiasis industry?
  • What are the attractive investment prepositions in the global Drugs for Schistosomiasis industry?
  • What are the key challenges faced by the industry participants in global Drugs for Schistosomiasis market?
  • What is the competitive scenario in global Drugs for Schistosomiasis industry?
  • Which are the major production geographies?
  • Who are the major regulatory bodies in global Drugs for Schistosomiasis industry?
  • Which are the major companies governing the global Drugs for Schistosomiasis industry?

Browse the full report at https://www.credenceresearch.com/report/drugs-for-schistosomiasis-market

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Media Contact
Company Name: Credence Research
Contact Person: Chris Smith
Email: Send Email
Phone: 18003618290
City: SAN JOSE
State: CA
Country: United States
Website: https://www.credenceresearch.com/report/drugs-for-schistosomiasis-market

Categories